Red Yeast Rice for Hypercholesterolemia
References
- Colantonio LD Bittner V Reynolds K Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies Circulation 2016 133 3 256 64
- Writing Group Members Mozaffarian D Benjamin EJ American Heart Association Statistics Committee; Stroke Statistics Subcommittee Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association Circulation 2016 133 4 e38 360
- NCD Risk Factor Collaboration (NCD-RisC) Trends in total cholesterol and lipid fractions in 22 Western and Asian countries Lancet 2019 (in press)
-
Booth
JN
3rd Colantonio LD Howard G Healthy lifestyle factors and incident heart disease and mortality in candidates for primary prevention with statin therapy Int J Cardiol 2016 207 196 202 - Arnett DK Blumenthal RS Albert MA 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Circulation 2019 Sep 10 140 11 e596 e646
- Piepoli MF Hoes AW Agewall S 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur J Prev Cardiol 2016 23 11 NP1 NP96
- Poli A Barbagallo CM Cicero AFG Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper Pharmacol Res 2018 134 51 60
- Patti AM Toth PP Giglio RV Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia Curr Pharm Des 2017 23 17 2496 2503
- Cicero AFG Colletti A Bajraktari G Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel Nutr Rev 2017 Sep 1 75 9 731 767
- Ma J Li Y Ye Q Constituents of red yeast rice, a traditional Chinese food and medicine J Agric Food Chem 2000 48 11 5220 5
- Gordon RY Cooperman T Obermeyer W Becker DJ Marked variability of monacolin levels in commercial red yeast rice products: buyer beware! Arch Intern Med. 2010 170 19 1722 7
- Endo A Monacolin K, a new hypocholesterolemic agent produced by a Monascus species J Antibiot (Tokyo) 1979 Aug 32 8 852 4
- Li YG Zhang F Wang ZT Hu ZB Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry J Pharm Biomed Anal 2004 35 5 1101 12
- Gerards MC Terlou RJ Yu H Koks CH Gerdes VE Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis Atherosclerosis 2015 240 2 415 23
- Zhao SP Liu L Cheng YC Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease Circulation 2004 110 8 915 20
- Cicero AF Morbini M Parini A Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects Ther Clin Risk Manag 2016 12 281 6
- Cicero AF Morbini M Rosticci M D'Addato S Grandi E Borghi C Middle-Term Dietary Supplementation with Red Yeast Rice Plus Coenzyme Q10 Improves Lipid Pattern, Endothelial Reactivity and Arterial Stiffness in Moderately Hypercholesterolemic Subjects Ann Nutr Metab 2016 68 3 213 9
- Li JJ Lu ZL Kou WR Chinese Coronary Secondary Prevention Study Group Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS) J Clin Pharmacol 2009 49 8 947 56
- Cicero AF Colletti A Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data Phytomedicine 2016 23 11 1113 8
- Banach M Patti AM Giglio RV International Lipid Expert Panel (ILEP) The Role of Nutraceuticals in Statin Intolerant Patients J Am Coll Cardiol 2018 Jul 3 72 1 96 118
- Cicero AF Parini A Rosticci M Nutraceuticals and cholesterol-lowering action Int J Cardiol Med Endocr 2015 6 1 4
- Varady KA Wang Y Jones PJ Role of policosanols in the prevention and treatment of cardiovascular disease Nutr Rev 2003 Nov 61 11 376 83
- Cicero AF Brancaleoni M Laghi L Donati F Mino M Antihyperlipidaemic effect of a Monascus purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: a pilot study Complement Ther Med 2005 13 4 273 8
- Stefanutti C Mazza F Vivenzio A Combined treatment with Dif1stat and diet reduce plasma lipid indicators of moderate hypercholesterolemia more effectively than diet alone: a randomized trial in parallel groups Lipids 2009 44 12 1141 8
- Cicero AF Benvenuti C AR Moweb study Group Efficacy of a red yeast rice based nutraceutical in large subgroups of hypercholesterolemic subjects in every day clinical practice Med J Nutr Metab 2010 3 239 46
- Guardamagna O Abello F Baracco V Stasiowska B Martino F The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols Nutr Metab Cardiovasc Dis 2011 21 6 424 9
- Pirro M Mannarino MR Bianconi V The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials Pharmacol Res 2016 110 76 88
- Marazzi G Cacciotti L Pelliccia F Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients Adv Ther 2011 28 12 1105 13
- De Castro-Orós I Solà R Valls RM Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine PLoS One 2016 11 3 e0150785
- Cicero AF Parini A Rosticci M Effect of a lipid-lowering nutraceutical on pulse-wave-velocity in hypercholesterolemic patients with or without chronic kidney disease Open Hypertens J 2013 5 1 18 22
- Pisciotta L Bellocchio A Bertolini S Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment Lipids Health Dis 2012 11 123
- Feuerstein JS Bjerke WS Powdered red yeast rice and plant stanols and sterols to lower cholesterol J Diet Suppl 2012 9 2 110 5
- Cicero AF Fogacci F Rosticci M Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: a three-arm, double-blind, randomized clinical trial Nutr Metab 2017 14 61
- Ogier N Amiot MJ Georgé S LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia Eur J Nutr 2013 52 2 547 57
- Barrat E Zaïr Y Ogier N A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial Int J Food Sci Nutr 2013 64 7 882 9
- Barrat E Zaïr Y Sirvent P Effect on LDL-cholesterol of a large dose of a dietary supplement with plant extracts in subjects with untreated moderate hypercholesterolaemia: a randomised, double-blind, placebo-controlled study Eur J Nutr 2013 52 8 1843 52
- Cicero AF Colletti A Fogacci F Bove M Rosticci M Borghi C Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial High Blood Press Cardiovasc Prev 2017 24 1 13 18
- Derosa G Bonaventura A Bianchi L A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters J Biol Regul Homeost Agents 2014 28 2 317 24
- Cicero AF Colletti A Rosticci M Grandi E Borghi C Efficacy and tolerability of a combined lipid-lowering nutraceutical on cholesterolemia, hs-CRP level and endothelial function in moderately hypercholesterolemic subjects J Biol Regul Homeost Agents 2016 30 2 593 8
- Cicero AF Derosa G Pisciotta L Barbagallo C SISA-PUFACOL Study Group Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study J Med Food 2015 18 11 1270 3
- Kantola T Kivistö KT Neuvonen PJ Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid Clin Pharmacol Ther 1998 63 4 397 402
- DFG Permanent Senate Commission on Food Safety Toxicological evaluation of red mould rice: An update [Internet] Kaiserslautern, Germany DFG-Senate Commission on Food Safety 2013 Nov 13 [cited 2019 Jun 11] 26 p. Available from: https://www.dfg.de/download/pdf/dfg_im_profil/reden_stellungnahmen/2013/131206_sklm_red_mould_rice_update.pdf
- Prasad GV Wong T Meliton G Bhaloo S Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient Transplantation 2002 74 8 1200 1
- Rasheva TV Nedeva TS Hallet JN Kujumdzieva AV Characterization of a non-pigment producing Monascus purpureus mutant strain Antonie Van Leeuwenhoek 2003 83 4 333 40
- Arai M Hibino T Tumorigenicity of citrinin in male F344 rats Cancer Lett 1983 17 3 281 7
- Singh ND Sharma AK Dwivedi P Patil RD Kumar M Experimentally induced citrinin and endosulfan toxicity in pregnant Wistar rats: histopathological alterations in liver and kidneys of fetuses J Appl Toxicol 2008 28 7 901 7
- EFSA Panel on Contaminants in the Food Chain (CONTAM) Scientific Opinion on the risks for public and animal health related to the presence of citrinin in food and feed EFSA Journal 2012 10 3 2605
- EFSA Panel on Food Additives and Nutrient Sources Added to Food Scientific opinion on the safety of monacolins in red yeast rice EFSA Journal 2018 16 8 5368
- Fogacci F Banach M Mikhailidis DP ; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group; International Lipid Expert Panel (ILEP) Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials Pharmacol Res 2019 143 1 16
- Hobbs FD Banach M Mikhailidis DP Malhotra A Capewell S Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate BMC Med 2016 14 4
- Baigent C Keech A Kearney PM ; Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 2005 366 9493 1267 78
- Baigent C Blackwell L Emberson J ; Cholesterol Treatment Trialists' (CTT) Collaboration Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 2010 376 9753 1670 81
- Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 2002 360 9326 7 22
- Cicero AF Colletti A Bajraktari G Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel Arch Med Sci 2017 13 5 965 1005
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of health claims related to monacolin K from red yeast rice and maintenance of normal blood LDL-cholesterol concentrations (ID 1648, 1700) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Journal 2011 9 7 2304
DOI: https://doi.org/10.14797/mdcj-15-3-192 | Journal eISSN: 1947-6108
Language: English
Page range: 192 - 199
Published on: Jul 1, 2019
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2019 Arrigo F.G. Cicero, Federica Fogacci, Maciej Banach, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.